Hosted on MSN1mon
FDA Accepts Bayer's Application for Label Expansion of NubeqaBayer BAYRY announced that the FDA has accepted its supplemental new drug application (sNDA) for Nubeqa (darolutamide). The sNDA is seeking label expansion ... and the regulatory body has set ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback